Provided by Tiger Trade Technology Pte. Ltd.

Assembly Biosciences

34.95
+1.323.91%
Volume:211.58K
Turnover:7.27M
Market Cap:711.50M
PE:-13.61K
High:35.30
Open:34.12
Low:33.43
Close:33.63
52wk High:39.71
52wk Low:20.23
Shares:20.36M
Float Shares:9.17M
Volume Ratio:0.84
T/O Rate:2.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0026
EPS(LYR):-0.5461
ROE:-0.03%
ROA:-2.67%
PB:2.33
PE(LYR):-63.99

Loading ...

Guggenheim Sticks to Its Buy Rating for Assembly Biosciences (ASMB)

TIPRANKS
·
May 11

Assembly Biosciences posts corporate presentation on antiviral pipeline for herpesviruses, hepatitis B and D

Reuters
·
May 08

Assembly Biosciences Q1 revenue falls, net loss widens

Reuters
·
May 08

Assembly Biosciences Q1 EPS $(0.54) Beats $(0.71) Estimate, Sales $8.213M Miss $9.266M Estimate

Benzinga Earnings
·
May 08

Assembly Bio Q1 FY26 net loss narrows to $9.1 million; revenue slips to $8.2 million

Reuters
·
May 08

Assembly Biosciences Q1 EPS USD -0.54

THOMSON REUTERS
·
May 08

Assembly Biosciences Q1 Net Income USD -9.079 Million

THOMSON REUTERS
·
May 08

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

GlobeNewswire
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Assembly Biosciences Inc expected to post a loss of 57 cents a share - Earnings Preview

Reuters
·
May 05

Assembly Biosciences Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
May 04

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

TIPRANKS
·
May 04

Assembly Bio highlights positive Phase 1b HSV data for ABI-5366 at ESCMID 2026

Reuters
·
Apr 09

Assembly Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 06

Assembly Biosciences price target raised to $43 from $39 at Guggenheim

TIPRANKS
·
Apr 06

Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan

TIPRANKS
·
Mar 31

Assembly Biosciences boosts CEO Okazaki bonus target to 65% under new cash plan

Reuters
·
Mar 31

Assembly Biosciences Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 26

Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial

TIPRANKS
·
Mar 24

Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives

Simply Wall St.
·
Mar 21